ARH-049020
CAS No. 251454-45-2
ARH-049020( —— )
Catalog No. M34165 CAS No. 251454-45-2
ARH-049020 (ARH049020) is a PPAR agonist used in the study of type 2 diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameARH-049020
-
NoteResearch use only, not for human use.
-
Brief DescriptionARH-049020 (ARH049020) is a PPAR agonist used in the study of type 2 diabetes.
-
DescriptionARH-049020 (ARH049020) is a PPAR agonist used in the study of type 2 diabetes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number251454-45-2
-
Formula Weight429.51
-
Molecular FormulaC24H31NO6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@H](OCC)C(O)=O)C1=CC=C(OCCC2=CC=C(NC(OC(C)(C)C)=O)C=C2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MSDC-0602K
MSDC-0602K (Azemiglitazone potassium) (Azemiglitazone potassium) is a PPARγ-sparing thiazolidinedione (Ps-TZD) compound that binds to PPARγ with an IC50 of 18.25 μM.
-
Saroglitazar
A novel PPAR agonist with predominant PPARα and moderate PPARγ activity with EC50 of 0.65 pM and 3 nM respectively.
-
T0070907
T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM.
Cart
sales@molnova.com